mercredi 2 mars 2016

Onco Actu du 2 mars 2016

1. Biologie

Study sheds new light on asbestos-related cancer [Cancer Research UK]

How Stress Affects Cancer’s Spread [The Scientist]

3.1 Tabac

‘I’m so upset that Stop Smoking Services are being closed down’ – Nicky’s story [Cancer Research UK]

E-cigarettes are estimated to have helped 16,000-22,000 smokers in England to quit in 2014 |[EurekAlert!]

3.3 Prévention - Vaccins

One more time: There’s no evidence Gardasil causes premature ovarian failure [Respectful Insolence]

4.9 Dép., diag. & prono. - Sein

Journal of Clinical Oncology Publishes Prospective Outcomes Results from Large International Trial Using Oncotype DX® [Genomic Health]

5. Traitements

Doubt cast on cancer drug target MTH1 [Chemical & Engineering News]

Single Dose of Trastuzumab Kick Starts Immune Response in Certain Breast Cancers [School of Medicine - Case Western Reserve University]

DNA Origami Used to Cloak Anti-Cancer Meds for Delivery Inside Drug Resistant Cells [Medgadget]

5.2 Pharma

EUSA Pharma and AVEO Announce Submission of Marketing Authorization Application for Tivozanib in Advanced Renal Cell Carcinoma [Aveo]

5.4 Traitements - Economie

U.K. cost watchdogs snub key J&J med Imbruvica on first go-around [FiercePharma]

UK cost agency rejects leukaemia drug from J&J and AbbVie [Reuters]

5.6 ESMO

Anti-Cancer Medicines Availability | International Study [ESMO]

6.1 Observation

Ethnic minority women more likely to believe that cancer is deadly and down to fate [Cancer Research UK]

6.11 Patients

Patients Must Be Part Of Defining Quality And Increasing Value [Health Affairs]

6.7 DMP, Big Data & applis

Why big pharma is turning to text mining [Science|Business]

6.7.3 DMP

New pact to make electronic health records 'work better' [CNBC]

6.9 Controverses

You might find my research using monkeys abhorrent, but it could save your life [The Guardian]